We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

ELEKTA

Elekta develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well a... read more Featured Products: More products

Download Mobile App




New European Partnership Designed to Increase Radiation Therapy Awareness

By HospiMedica International staff writers
Posted on 15 Feb 2017
A new partnership has been agreed between a European cancer foundation and a human care company to optimize patient access to state-of-the-art radiation therapy in Europe.

The partnership will address patient access to radiation therapy, as part of the comprehensive cancer care cycle, in Eastern and South-Eastern Europe by initiating programs with industry and academic partners, and patient advocacy groups.

The European Society for Radiotherapy & Oncology (ESTRO) Cancer Foundation and Elekta agreed the new partnership. More...
The ECF aims to provide access to state-of-the-art radiation therapy as part of a multidisciplinary approach for personalized cancer care. Elekta is a human care company that develops tools and treatment planning systems for radiation therapy, brachytherapy, radiosurgery, brain disorders, and software intended to enhance the cancer care workflow.

Senior VP Elekta, Region Europe, Francois Pointurier, said, "Elekta has had a strong relationship with ESTRO for many years. With the other partners working with ECF, we are stronger in our mission to ensure that individuals in every European country that could benefit from radiation therapy receive the treatment they need. With hope and hard work this partnership will radically improve the visibility of radiation therapy within Europe and parts of Asia. A 2013 Lancet study showed that dated cobalt 60 technology is still in significant use in parts of east and southeast Europe. In addition, in 28 of the 33 European countries studied, there were less than four radiotherapy machines per radiation therapy center. Especially in east and southeast Europe, countries need to expand and modernize their radiation therapy equipment."


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Infrared Digital Thermometer
R1B1
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.